Zürcher Nachrichten - Pfizer seeks US approval of Covid vaccine for children under 5

EUR -
AED 3.821609
AFN 73.043711
ALL 98.561994
AMD 415.734952
ANG 1.874008
AOA 948.892795
ARS 1067.239304
AUD 1.668181
AWG 1.872815
AZN 1.757682
BAM 1.956454
BBD 2.099482
BDT 124.256752
BGN 1.957817
BHD 0.392426
BIF 3074.798113
BMD 1.040453
BND 1.412959
BOB 7.185402
BRL 6.442694
BSD 1.039838
BTN 88.511732
BWP 14.441688
BYN 3.402905
BYR 20392.87375
BZD 2.092379
CAD 1.496535
CDF 2986.099191
CHF 0.93648
CLF 0.037319
CLP 1029.739995
CNY 7.591767
CNH 7.598484
COP 4556.381863
CRC 527.971385
CUC 1.040453
CUP 27.571998
CVE 110.297624
CZK 25.115501
DJF 185.171889
DKK 7.460816
DOP 63.34117
DZD 140.687327
EGP 52.961546
ERN 15.606791
ETB 132.39725
FJD 2.412966
FKP 0.82402
GBP 0.828196
GEL 2.923108
GGP 0.82402
GHS 15.285109
GIP 0.82402
GMD 74.912518
GNF 8986.65805
GTQ 8.0096
GYD 217.552711
HKD 8.081868
HNL 26.41983
HRK 7.46307
HTG 135.964135
HUF 410.690109
IDR 16866.571316
ILS 3.790359
IMP 0.82402
INR 88.614737
IQD 1362.155262
IRR 43790.051599
ISK 145.091415
JEP 0.82402
JMD 162.007918
JOD 0.737991
JPY 163.632522
KES 134.384575
KGS 90.519253
KHR 4179.356665
KMF 484.981066
KPW 936.406886
KRW 1516.386879
KWD 0.320615
KYD 0.866581
KZT 538.684863
LAK 22740.381777
LBP 93117.221839
LKR 306.450641
LRD 189.251433
LSL 19.334876
LTL 3.072187
LVL 0.629359
LYD 5.10451
MAD 10.485801
MDL 19.185228
MGA 4904.592084
MKD 61.579021
MMK 3379.349922
MNT 3535.458283
MOP 8.3185
MRU 41.508277
MUR 48.974372
MVR 16.027812
MWK 1803.102637
MXN 20.964801
MYR 4.668508
MZN 66.48881
NAD 19.335062
NGN 1610.226956
NIO 38.262788
NOK 11.815418
NPR 141.618971
NZD 1.843304
OMR 0.40057
PAB 1.039848
PEN 3.871945
PGK 4.220248
PHP 60.807174
PKR 289.478921
PLN 4.256856
PYG 8109.710445
QAR 3.781864
RON 4.974508
RSD 116.972699
RUB 104.513453
RWF 1450.570871
SAR 3.90625
SBD 8.722693
SCR 14.683216
SDG 625.834202
SEK 11.538871
SGD 1.414875
SHP 0.82402
SLE 23.721196
SLL 21817.776932
SOS 594.292914
SRD 36.476165
STD 21535.271101
SVC 9.098691
SYP 2614.168982
SZL 19.343279
THB 35.541837
TJS 11.375802
TMT 3.651989
TND 3.315608
TOP 2.436845
TRY 36.690385
TTD 7.066294
TWD 34.011368
TZS 2517.895925
UAH 43.598696
UGX 3806.235546
USD 1.040453
UYU 46.28369
UZS 13423.970506
VES 53.661818
VND 26469.117766
VUV 123.524633
WST 2.87455
XAF 656.17
XAG 0.035166
XAU 0.000398
XCD 2.811876
XDR 0.797259
XOF 656.151075
XPF 119.331742
YER 260.503326
ZAR 19.427453
ZMK 9365.323193
ZMW 28.777618
ZWL 335.025359
  • RBGPF

    -0.7000

    59.8

    -1.17%

  • CMSC

    -0.2094

    23.6927

    -0.88%

  • RIO

    -0.0810

    59.149

    -0.14%

  • CMSD

    -0.1590

    23.391

    -0.68%

  • NGG

    -0.3390

    58.681

    -0.58%

  • BTI

    0.0050

    36.225

    +0.01%

  • GSK

    -0.0650

    33.995

    -0.19%

  • RELX

    0.1500

    45.74

    +0.33%

  • SCS

    -0.0050

    11.645

    -0.04%

  • AZN

    -0.3650

    66.265

    -0.55%

  • BP

    0.0450

    28.795

    +0.16%

  • BCC

    0.5200

    122.76

    +0.42%

  • RYCEF

    -0.0200

    7.25

    -0.28%

  • JRI

    0.0430

    12.143

    +0.35%

  • BCE

    0.1150

    22.955

    +0.5%

  • VOD

    0.0900

    8.46

    +1.06%

Pfizer seeks US approval of Covid vaccine for children under 5
Pfizer seeks US approval of Covid vaccine for children under 5

Pfizer seeks US approval of Covid vaccine for children under 5

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years.

Text size:

If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in the United States.

The companies said Tuesday that they started submitting their formal application "following a request" from the FDA, which seemingly wants to get the process moving quickly.

In a tweet soon after the announcement, the FDA said it will hold a meeting in two weeks, on February 15, to consider the request.

"Having a safe and effective vaccine available for children in this age group is a priority for the agency," said interim FDA head Janet Woodcock, who added that the FDA asked for the application "in light of the recent Omicron surge."

The companies are seeking authorization for only two doses of their vaccine, but believe a third will be needed "to achieve high levels of protection against current and potential future variants," Pfizer CEO Albert Bourla said in a statement.

"If two doses are authorized, parents will have the opportunity to begin a Covid-19 vaccination series for their children while awaiting potential authorization of a third dose," he added.

To limit side effects for this young age group, Pfizer chose to significantly decrease the dosage of its vaccine, opting for only three micrograms per jab versus 30 for those over 12 years old, and 10 for ages five to 11.

The company's researchers concluded last fall that low doses of the vaccine provided protection in children up to two years old but not in those aged two to five, and announced in December they would add a third dose to their trials.

Data on the three-dose regimen is "expected in the coming months and will be submitted to the FDA to support a potential expansion" of this initial request, Pfizer and BioNTech said in the statement.

If the FDA authorizes the emergency use of the vaccine, an advisory committee for the Centers for Disease Control and Prevention (CDC) will then meet to decide to recommend its use or not.

- Slower uptake among minors -

There are about 23 million children under the age of five in the United States, and two years after the pandemic began, many parents are waiting impatiently to vaccinate their young children against the coronavirus.

The Pfizer-BioNTech vaccine was approved three months ago for emergency use in children from five to 11, but uptake has been relatively slow.

In that age group, only 30 percent have received at least one dose and around 22 percent are fully vaccinated, according to the Centers for Disease Control and Prevention (CDC).

Young children are less susceptible to falling seriously ill with Covid-19, but some nonetheless end up hospitalized by the virus.

New pediatric Covid hospitalizations hit a record high in the United States in December as the Omicron strain spread rapidly.

Some cases of the life-threatening illness MIS-C (multi-system inflammatory syndrome in children), have also been reported in young children with Covid.

CDC data shows that about 400 children aged four and under have died from Covid-19 in the United States since the pandemic began.

L.Zimmermann--NZN